Literature DB >> 326810

Glucagon and insulin binding to liver membranes in a partially nephrectomized uremic rat model.

V Soman, P Felig.   

Abstract

To investigate the role of glucagon and insulin receptor binding in the glucagon hypersensitivity and insulin resistance which characterize the glucose intolerance of uremia, liver plasma membranes were prepared from control rats (blood urea nitrogen [BUN] 15+/-1 mg/100 ml, creatinine 0.7+/-0.2 mg/100 ml), and from 70% nephrectomized rats (BUN 30+/-2 mg/100 ml, creatinine 2.2+/-0.2 mg/100 ml), and from 90% nephrectomized rats (BUN 46+/-3 mg/100 ml, creatinine 4.20+/-0.7 mg/100 ml), 4 wk after surgery. As compared to controls, the 90% nephrectomized rats had significantly higher levels of plasma glucose (95+/-4 vs. 125+/-11 mg/100 ml), plasma insulin (28+/-9 vs. 52+/-11 muU/ml), and plasma glucagon (28+/-5 vs. 215+/-18 pg/ml). Similar, but less marked, elevations were observed in the 70% nephrectomized animals. In liver plasma membranes from nephrectomized rats, specific binding of (125)I-glucagon was increased by 80-120%. Furthermore, glucagon (2 muM)-stimulated adenylate cyclase activity in nephrectomized rats was twofold higher than in controls. In contrast, fluoridestimulated adenylate cyclase activity was similar in both groups of rats. In marked contrast to glucagon binding, specific binding of (125)I-insulin to liver membranes from nephrectomized rats was reduced by 40-50% as compared to controls. Data analysis suggested that the changes in both glucagon and insulin binding are a consequence of alterations in binding capacity rather than changes in affinity. Liver plasma membranes from nephrectomized rats degraded (125)I-glucagon and (125)I-insulin to the same extent as control rats. THESE RESULTS DEMONSTRATE THAT: (a) the 70 and 90% nephrectomized rats simulate the hyperglycemia, hyperinsulinemia, and hyperglucagonemia observed in clinical uremia; (b) in these animals specific binding of glucagon to liver membranes is increased and is accompanied by higher glucagon-stimulated adenylate cyclase activity; and (c) specific binding of insulin is markedly decreased. These findings thus provide evidence of oppositely directed, simultaneous changes in glucagon and insulin receptor binding in partially nephrectomized rats. Such changes may account for the hypersensitivity to glucagon and may contribute to resistance to insulin observed in the glucose intolerance of uremia.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 326810      PMCID: PMC372360          DOI: 10.1172/JCI108759

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  36 in total

1.  Preparation of iodine-131 labelled human growth hormone of high specific activity.

Authors:  W M HUNTER; F C GREENWOOD
Journal:  Nature       Date:  1962-05-05       Impact factor: 49.962

2.  Use of glucose oxidase, peroxidase, and O-dianisidine in determination of blood and urinary glucose.

Authors:  A S HUGGETT; D A NIXON
Journal:  Lancet       Date:  1957-08-24       Impact factor: 79.321

3.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

4.  Azotemia and glucose intolerance.

Authors:  J M Cerletty; N H Engbring
Journal:  Ann Intern Med       Date:  1967-06       Impact factor: 25.391

5.  Influence of glucocorticoids on glucagon secretion and plasma amino acid concentrations in man.

Authors:  J K Wise; R Hendler; P Felig
Journal:  J Clin Invest       Date:  1973-11       Impact factor: 14.808

6.  Hyperglucagonemia of renal failure.

Authors:  G L Bilbrey; G R Faloona; M G White; J P Knochel
Journal:  J Clin Invest       Date:  1974-03       Impact factor: 14.808

7.  Pathogenesis and characterization of hyperglucagonemia in the uremic rat.

Authors:  D S Emmanouel; J B Jaspan; S F Kuku; A H Rubenstein; A I Katz; A H Huen
Journal:  J Clin Invest       Date:  1976-11       Impact factor: 14.808

8.  Correlation between insulin receptor binding in isolated fat cells and insulin sensitivity in obese human subjects.

Authors:  L C Harrison; F I Martin; R A Melick
Journal:  J Clin Invest       Date:  1976-12       Impact factor: 14.808

9.  Effects of fasting on insulin binding, glucose transport, and glucose oxidation in isolated rat adipocytes: relationships between insulin receptors and insulin action.

Authors:  J M Olefsky
Journal:  J Clin Invest       Date:  1976-12       Impact factor: 14.808

10.  Increased insulin binding by hepatic plasma membranes from diabetic rats: normalization by insulin therapy.

Authors:  M B Davidson; S A Kaplan
Journal:  J Clin Invest       Date:  1977-01       Impact factor: 14.808

View more
  8 in total

1.  Glucagon binding and adenylate cyclase activity in liver membranes from untreated and insulin-treated diabetic rats.

Authors:  V Soman; P Felig
Journal:  J Clin Invest       Date:  1978-03       Impact factor: 14.808

2.  Effects of glucose-containing peritoneal-dialysis solutions on rates of lipogenesis in vivo in the liver, brown and white adipose tissue of chronic uraemic rats.

Authors:  R A Klim; D H Williamson
Journal:  Biochem J       Date:  1983-08-15       Impact factor: 3.857

3.  Carbohydrate metabolism and uraemia-mechanisms for glycogenolysis and gluconeogenesis.

Authors:  W H Hörl; J Stepinski; A Heidland
Journal:  Klin Wochenschr       Date:  1980-10-01

4.  Glucagon-stimulable adenylyl cyclase in rat liver. Effects of chronic uremia and intermittent glucagon administration.

Authors:  R R Dighe; F J Rojas; L Birnbaumer; A J Garber
Journal:  J Clin Invest       Date:  1984-04       Impact factor: 14.808

5.  Abnormal carbohydrate metabolism in chronic renal failure. The potential role of accelerated glucose production, increased gluconeogenesis, and impaired glucose disposal.

Authors:  S Rubenfeld; A J Garber
Journal:  J Clin Invest       Date:  1978-07       Impact factor: 14.808

6.  Regulatory effect of glucagon on its own receptor concentrations and target-cell sensitivity in the rat.

Authors:  A Santos; E Blazquez
Journal:  Diabetologia       Date:  1982-05       Impact factor: 10.122

Review 7.  Role of the kidney in hormone metabolism and its implications in clinical medicine.

Authors:  D S Emmanouel; M D Lindheimer; A I Katz
Journal:  Klin Wochenschr       Date:  1980-10-01

8.  Insulin resistance in uremia.

Authors:  R A DeFronzo; A Alvestrand; D Smith; R Hendler; E Hendler; J Wahren
Journal:  J Clin Invest       Date:  1981-02       Impact factor: 14.808

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.